Lumexa Imaging Reports Q1 Profit, Strong EPS Growth, and Strategic Expansion
LMRI sits 45% above its 52-week low of $7.23.
Summary
Lumexa Imaging reported a swing to profitability in Q1 2026 with strong adjusted EPS growth and announced new center expansions, while reiterating its full-year guidance.
Key Events · Earnings and Guidance · LMRI
-
Q1 Net Income Achieved
The company reported a net income of $1.7 million for Q1 2026, a significant improvement from a net loss of $7.7 million in the prior year period.
-
Strong Adjusted EPS Growth
Adjusted EPS increased to $0.18 per share in Q1 2026, up from $0.04 per share in Q1 2025.
-
Strategic Expansion with New Centers
Lumexa Imaging announced the addition of four new centers, comprising two strategic tuck-in acquisitions and two de novo centers, advancing its growth strategy.
-
Full-Year Guidance Reiterated
The company reiterated its full-year 2026 outlook for consolidated revenues, Adjusted EBITDA, and Adjusted EPS, indicating confidence in its financial targets.
Analysis · LMRI · Industrial Applications And Services
Lumexa Imaging Holdings, Inc. reported a significant turnaround in its first quarter 2026 financial results, moving from a net loss to a net income of $1.7 million. The company also achieved strong adjusted EPS growth and announced the addition of four new imaging centers, including two strategic acquisitions, demonstrating continued operational expansion. Full-year guidance was reiterated, signaling management's confidence in sustained performance.
At the time of this filing, LMRI was trading at $10.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1B. The 52-week trading range was $7.23 to $19.45. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.